Bibliography
Export 2861 results:
A Preterm Neonate with Mycobacterium Fortuitum Infection. HK J Paediatr. 2009;14:1.
Prevalence and clinical consequences of herpes simplex virus type 1 DNA in human cornea tissues. J Infect Dis. 2009;200(1):11-9.
Prevalence of hepatitis E virus infection in liver transplant recipients. Liver Transpl. 2009;15(10):5.
Primary Containment for Biohazards Selection Installation and Use of Biological Safety Cabinets. Biosafety in Microbiological and Biomedical Laboratories (BMBL) 5th Edition. 2009.
Probiotic-associated high-titer anti-B in a group A platelet donor as a cause of severe hemolytic transfusion reactions. Transfusion//Transfusion. 2009;49(9):1845-9.
Prospective evaluation of the threat related to the use of seminal fractions from hepatitis C virus-infected men in assisted reproductive techniques. Hum Reprod. 2009;24(3):530-5.
Reconstruction of a human hemicornea through natural scaffolds compatible with the growth of corneal epithelial stem cells and stromal keratocytes. Mol Vis. 2009;15:2084-93.
Regionally limited or rare infections: prevention after hematopoietic cell transplantation. Bone Marrow Transplant. 2009;44(8):489-94.
A retrospective case note review of deceased recipients of vCJD-implicated blood transfusions. //Vox Sang. 2009;97(3):211-218.
Risk of contamination of germplasm during cryopreservation and cryobanking in IVF units. Hum Reprod. 2009;24(10):2457-67.
Risk of Creutzfeldt-Jakob disease transmission by ocular surgery and tissue transplantation. Eye (Lond). 2009;23(10):1926-30.
The Role of Testing in Determining Suitability of Donors and Tissues. In: Warwick R, Fehily D, Brubaker S, Eastlund T, editors. Tissue and Cell Donation: An Essential Guide. Oxford, England: Wiley-Blackwell Publishing; 2009. 1. p. 116-133p.
Safety and efficacy of hematopoietic stem cell collection from mobilized peripheral blood in unrelated volunteers: 12 years of single-center experience in 3928 donors. Blood. 2009;114(18):3757-63.
Safety and efficacy of hematopoietic stem cell collection from mobilized peripheral blood in unrelated volunteers: 12 years of single-center experience in 3928 donors. Blood. 2009;114(18):3757-63.
Sarcomatoid renal cell carcinoma in a renal transplant recipient. Transplantation Proceedings. 2009;41(10).
Sarcomatoid renal cell carcinoma in a renal transplant recipient. Transplant Proc. 2009;41(10):22.
Seroprevalence of Babesia microti in blood donors from Babesia-endemic areas of the northeastern United States: 2000 through 2007. //Transfusion. 2009;49(12):2574-2582.
Severe allergic reaction with anaphylaxis to G-CSF (lenograstim) in a healthy donor. Bone Marrow Transplant. 2009;44(2):129-30.
Severe events in donors after allogeneic hematopoietic stem cell donation. Haematologica. 2009;94(1):94-101.
Severe hemolytic anemia post-renal transplantation produced by donor anti-D passenger lymphocytes: case report and literature review. Transfusion medicine reviews//Transfus Med Rev. 2009;23(2):155-9.
Severe neurotoxicity associated with dimethyl sulphoxide following PBSCT. Bone Marrow Transplant. 2009;44(5):323-4.
Short and long-term safety of lenograstim administration in healthy peripheral haematopoietic progenitor cell donors: a single centre experience. Bone Marrow Transplantation. 2009;44(3):163-8.
Stem cell donation - What advice can be given to the donor? British Journal of Haematology. 2009;147(1):71-76.
Strongyloides stercoralis hyperinfection after allogeneic stem cell transplantation. Bone Marrow Transplant. 2009;43(9):741-742.